Loading clinical trials...
Loading clinical trials...
Clinical Investigation of AcrySof IQ PanOptix Toric Intraocular Lens Model TFNT20
The purpose of this study is to evaluate the effectiveness and safety of the TFNT20 low cylinder power intraocular lens when implanted in the eye to replace the natural lens following cataract removal.
Subjects will attend a total of 5 to 9 visits, depending on whether one eye or both eyes are implanted. The second eye surgery, if applicable, will occur 1 to 30 days after the first eye surgery. Total individual duration of participation will be up to 4 months, including an up to 2-month preoperative period. This study will be conducted in Japan.
Age
20 - No limit years
Sex
ALL
Healthy Volunteers
No
Alcon Investigative Site
Chiyoda-Ku, Tokyo, Japan
Start Date
December 1, 2020
Primary Completion Date
August 10, 2021
Completion Date
August 10, 2021
Last Updated
August 17, 2022
32
ACTUAL participants
ACRYSOF IQ PanOptix Toric Trifocal IOL
DEVICE
Cataract surgery
PROCEDURE
Lead Sponsor
Alcon Research
NCT06102109
NCT05852470
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04890249